Raffles Medical Group Likely Has Ability to Enhance Shareholder Returns -- Market Talk

Dow Jones
01/06

0638 GMT - Raffles Medical Group likely has the ability to enhance shareholder returns, CGS International's Tay Wee Kuang says in a research report. Given its net cash position of around S$283 million as of 1H 2025, the healthcare provider could boost shareholder returns via ways such as special dividends, the analyst says. With 2026 as the Singapore-listed company's 50th anniversary, it could augment its core dividend of 2.5 Singapore cents with additional 2.5 Singapore cents to bring 2025's dividend to 5.0 Singapore cents. The brokerage raises the stock's target price to S$1.23 from S$1.20 to reflect a valuation roll-forward, with an unchanged add rating. Shares are unchanged at S$1.01. (ronnie.harui@wsj.com)

 

(END) Dow Jones Newswires

January 06, 2026 01:38 ET (06:38 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10